Two of these mutations (Leu l OSTOP and Argl51STOP) are found in patients with vJNCL/GROD.' However, in these cases nonsense mutations do not occur in homozygous form and are only found in combination with a missense mutation. Therefore, we can now show that two clinically distinct forms of NCL are caused by shared mutations in PPT. The clinical significance of these findings is that the severity of the disease in these patients is dependent on the combination and type of mutations present.
There are several diseases in which different mutations in the same gene cause dissimilar clinical phenotypes, for example, CFTR (cystic fibrosis and congenital bilateral absence of the vas deferens4). Types A and B Niemann-Pick disease, like the NCLs, are lysosomal storage disorders which are both caused by mutations in the acid sphingomyelinase gene. As in this study, the same mutation has been found in both forms and the age of onset and severity of the phenotype is dependent on the other allele. ' Geographical clustering of a rare autosomal recessive genetic disease suggests a founder effect with patients inheriting the same ancestral disease chromosomes. Detailed genealogical information is not available on these patients. However, all but one of the 18 disease chromosomes in INCL and vJNCL/GROD cases are accounted for by two nonsense and one missense mutations ( Bold type indicates mutations present in both INCL and vJNCIJGROD. (SSCP) . Samples displaying mobility shifts were subjected to DNA sequence analysis. This analysis failed to detect homozygous deletions of the PTEN gene in any sample. A heterozygous mutation was identified in only one of the prostate tumour samples and was characterised as a single base deletion in codon 68 (TAC-*AC). Additionally, an A-+G polymorphism 96 bp upstream of the beginning of exon 2 was found in nine of 28 samples (32.1%). Based on this analysis, we conclude that mutations of the PTEN gene are rare in primary prostate cancers.
